Introduction Chemotherapy-induced neurotoxicity is a significant source of morbidity for
cancer patients. This study aimed to assess the relationship between preexisting diabetes …

Objective Considering the increasing number of treatment options for metastatic breast
cancer (MBC), it is important to develop high-quality methods to assess the cost …

Home‐based chemotherapy (HC) is a new treatment alternative to hospital‐based
chemotherapy treatment (IP) and is administered via portable intravenous pumps at the …

Background: Current patient selection for adjuvant chemotherapy (ACT) after curative
surgery for stage II colon cancer (CC) is suboptimal, causing overtreatment of high-risk …

Several adjuvant chemotherapy regimens exist for the treatment of stage III colon cancer. In
conjunction with the clinical data from randomized trials, cost-effectiveness studies might …

Background Ovarian cancer is a leading cause of cancer-related mortality. Although the
disease is relatively rare, it carries a disproportionately large morbidity burden. Objective We …

AIM: To compare XELOX and FOLFOX4 as colon cancer adjuvant chemotherapy based on
MOSAIC and No. 16968 trails from Chinese cost-effectiveness perspective. METHODS: A …

Simple Summary There are various chemotherapy regimens used to treat patients
diagnosed with stage III colorectal cancer, one of which is an oral chemotherapy drug called …

Background: Our aim was to evaluate the cost effectiveness of 3 months' adjuvant
chemotherapy versus 6 months in high-risk (T4 stage+ microsatellite stable) stage II colon …

Adjuvant chemotherapy of leucovorin‐modulated 5‐fluorouracil (5‐FU/LV), capecitabine,
and adding oxaliplatin to 5‐FU/LV or capecitabine (FLOX/OX) have been standard regimens …